Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance
This work was supported by grants from the Asociacion Espanola Contra el Cancer (AECC, Hereditary Cancer coordinated group, 2010; AECC Barcelona Ovarian Cancer 2015), the Generalitat de Catalunya (SGR 2014-364 and 2017-449), the Ministerio de Economia y Competitividad (SAF2013-45836-R and SAF2017-87811R), European Regional Development Fund (ERDF/FEDER "Una manera de hacer Europa"), the Instituto de Salud Carlos III (PIE13/00022-ONCOPROFILE, FIS PI13/01339, PI15/00854, PI16/01898 and RTICC RD12/0036/0008), and Fundacion Mutua Madrilena (AP150932014). A.D-N. is supported by the Department of Education of the Basque Government (PRE-2017-1-0100). ; Ruiz de Garibay, G., Mateo, F., Stradella, A., Valdés-Mas, R., Palomero, L., Serra-Musach, J., Puente, D.A., Dıáz-Navarro, A., Vargas-Parra, G., Tornero, E., Morilla, I., Farré, L., Martinez-Iniesta, M., Herranz, C., McCormack, E., Vidal, A., Petit, A., Soler, T., Lázaro, C., Puente, X.S., Villanueva, A., Pujana, M.A.